Skip to main content

Wheezing clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness

    open to eligible people ages 6 months to 18 months

    The primary objective of this study is to evaluate if Broncho-Vaxom® given to high risk infants for 10 days, monthly, for two consecutive years can increase time to occurrence of the first episode of wheezing lower respiratory tract illness (WLRI) during a third observation year after therapy

    Oakland, California and other locations

Last updated: